Gene-environment interaction: A central concept in multifactorial diseases

Proceedings of the Nutrition Society

Volumn 61, Issue 4, 2002, Pages 457-463

  Tiret, Laurence ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Common diseases; Gene environmment interaction

Indexed keywords

CLINICAL TRIAL; CONCEPT FORMATION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HUMAN; MULTIFACTORIAL GENETIC DISORDER; PATHOGENESIS; PHENOTYPE; POPULATION RISK; PROTEIN INTERACTION; RISK FACTOR; STRESS;

ALCOHOL DRINKING; BLOOD PRESSURE; BODY MASS INDEX; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY DISEASE; ENDOTHELIN-1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; LIFE STYLE; LIPOPROTEIN LIPASE; MYOCARDIAL INFARCTION; TRIGLYCERIDES;

EID: 0036871146     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2002178     Document Type: Conference Paper

References (17)

1. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L & Cambien F (2000) Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genetic Epidemiology 19, 64-80.
2. Dachet C, Poirier O, Cambien F, Chapman J & Rouis M (2000) New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arteriosclerosis, Thrombosis and Vascular Biology 20, 507-515.
3. European Atherosclerosis Research Study Group (1994) The European Atherosclerosis Research Study: design and objectives. International Journal of Epidemiology 23, 465-471.
4. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G & Santucci A (1995) Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. Journal of Clinical Endocrinology and Metabolism 80, 829-835.
5. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard JM, Fruchart JC, Ducimetière P, Apfelbaum M & Cambien F (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. Journal of Clinical Investigation 96, 1664-1671.
6. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ & Faergeman O (1997) Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations - Studies in the fasting and postprandial states: The European Atherosclerosis Research Studies. Circulation 96, 733-740.
7. Gordon DJ & Rifkind BM (1989) HDL - the clinical implications of recent studies. New England Journal of Medicine 321, 1311-1316.
8. Humphries SE, Nicaud V, Margalef J, Tiret L & Talmud PJ (1998) Lipoprotein lipase gene variation is associated with paternal history of premature coronary artery disease and fasting and post-prandial plasma triglycerides: European Atherosclerosis Research Study. Arteriosclerosis, Thrombosis and Vascular Biology 18, 526-534.
9. Karpe F (1999) Postprandial lipoprotein metabolism and atherosclerosis. Journal of Internal Medicine 246, 341-355.
10. Krum H, Viskoper RJ, Lacourciere Y, Budde M & Charlon V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. New England Journal of Medicine 338, 784-790.
11. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI & Kastelein JJ (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. New England Journal of Medicine 338, 86-93.
12. Levin ER (1995) Endothelins. New England Journal of Medicine 333, 356-363.
13. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ & Dargie HJ (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350, 829-833.
14. Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F & De Baker G (1994) Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. Circulation 89, 1967-1973.
15. Tall AR (1993) Plasma cholesteryl ester transfer protein. Journal of Lipid Research 34, 1255-1274.
16. Tiret L, Poirier O, Hallet V, McDonagh T, Morrison C, McMurray J, Dargie H, Arveiler D, Ruidavets J, Luc G, Evans A & Cambien F (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33, 1169-1174.
17. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 3, 473-485.